Measurement of temporal regional cerebral perfusion with single-photon emission tomography predicts rate of decline in language function and survival in early Alzheimer’s disease

Abstract. We determined the relationship between regional cerebral blood flow (rCBF) measured with single-photon emission tomography (SPET) and decline in cognitive function and survival in Alzheimer’s disease. In a prospective follow-up study, 69 consecutively referred patients with early probable Alzheimer’s disease (NINCDS/ADRDA criteria) underwent SPET performed at the time of initial diagnosis using technetium-99m-labelled hexamethylpropylene amine oxime. Neuropsychological function was assessed at baseline and after 6 months and survival data were available on all patients, extending to 5.5 years of follow-up. Lower left temporal (P<0.01) and lower left parietal (P<0.01) rCBF were statistically significantly related to decline in language function after 6 months. The association between left temporal rCBF and survival was also statistically significant (P<0.05) using Cox proportional hazards regression analysis. Performing analysis with quartiles of the distribution, we found a threshold effect for low left temporal rCBF (rCBF<73.7%, P<0.01) and high risk of mortality. In this lowest quartile, median survival time was 2.7 years (follow-up to 5.2 years), compared with 4.4 years in the other quartiles (follow-up to 5.5 years). Kaplan-Meier survival curves showed statistically significant (P<0.05, log rank test) survival curves for the lowest versus other quartiles of left temporal rCBF. All results were unaffected by adjustment for age, sex, dementia severity, duration of symptoms, education and ratings of local cortical atrophy. We conclude that left temporal rCBF predicts decline in language function and survival in patients with early probable Alzheimer’s disease, with a threshold effect of low rCBF and high risk of mortality.

[1]  William J. Jagust,et al.  Reduced temporal lobe blood flow in alzheimer's disease , 1992, Neurobiology of Aging.

[2]  H. Welch,et al.  Survival of outpatients with Alzheimer-type dementia. , 1990, Annals of internal medicine.

[3]  R. Levy,et al.  Factors affecting survival in Alzheimer's disease , 1991, Psychological Medicine.

[4]  R. Leiguarda,et al.  Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.

[5]  E. P. Krenning,et al.  The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease , 1994, Neurology.

[6]  J. Haxby,et al.  Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. , 1986, Archives of neurology.

[7]  L. Gwyther,et al.  Early‐onset Alzheimer's disease , 1987, Neurology.

[8]  C. Pieper,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIV , 1996, Neurology.

[9]  Yaakov Stern,et al.  Increased risk of mortality in alzheimer's disease patients with more advanced educational and occupational attainment , 1995, Annals of neurology.

[10]  R. ter Horst,et al.  Some psychometric properties of the CAMCOG , 1993, Psychological Medicine.

[11]  A. Kaszniak,et al.  Predictors of mortality in presenile and senile dementia , 1978, Annals of neurology.

[12]  David Collett Modelling Survival Data in Medical Research , 1994 .

[13]  S Minoshima,et al.  Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[15]  J. Growdon,et al.  Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease. , 1990, Archives of internal medicine.

[16]  A. Hijdra,et al.  Relation of leukoaraiosis to lesion type in stroke patients. , 1990, Stroke.

[17]  J. C. Stoof,et al.  Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease. , 1995, Nuclear medicine and biology.

[18]  J. Brandt,et al.  Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging , 1996, Neurology.

[19]  D Wyper,et al.  Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[20]  R A Zimmerman,et al.  The effect of focal cerebral atrophy in positron emission tomographic studies of aging and dementia. , 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[21]  M. Albert,et al.  Predicting time to nursing home care and death in individuals with Alzheimer disease. , 1997, JAMA.

[22]  P. Mölsä,et al.  Long‐term survival and predictors of mortality in Alzheimer's disease and multi‐infarct dementia , 1995, Acta neurologica Scandinavica.

[23]  G. Paxinos,et al.  Atlas of the Human Brain , 2000 .

[24]  W. Jagust,et al.  Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease , 1989, Neurology.

[25]  R. Lévy,et al.  Computed Tomography in the Elderly: 1. the Normal Population , 1980, British Journal of Psychiatry.

[26]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[27]  M. Roth CAMDEX : the Cambridge examination for mental disorders of the elderly , 1999 .

[28]  J. Haxby,et al.  Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. , 1990, Archives of neurology.

[29]  W. Jagust,et al.  Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. , 1995, Archives of neurology.

[30]  C. Pozzilli,et al.  Factors affecting course and survival in Alzheimer's disease. A 9-year longitudinal study. , 1994, Archives of neurology.

[31]  N. Lassen,et al.  Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[32]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[33]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[34]  B L Holman,et al.  The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  B. Sahakian,et al.  A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[36]  W. Jagust,et al.  Cognitive correlates of regional cerebral blood flow in Alzheimer's disease. , 1993, Archives of neurology.

[37]  G. Walstra,et al.  [CAMDEX-N: the Dutch version of the Cambridge Examination for Mental Disorders of the Elderly with automatic data processing]. , 1991, Tijdschrift voor gerontologie en geriatrie.

[38]  A. Stone,et al.  Predictors of survival with Alzheimer's disease: a community-based study , 1995, Psychological Medicine.

[39]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[40]  W. D. Ray 4. Modelling Survival Data in Medical Research , 1995 .

[41]  W. V. van Gool,et al.  Reversible dementia in elderly patients referred to a memory clinic , 1996, Journal of Neurology.

[42]  K M Heilman,et al.  Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: a volumetric magnetic resonance imaging study. , 1997, Neuropsychiatry, neuropsychology, and behavioral neurology.